|
DCP1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.822600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.973800E-01 |
| Normal-vs-Stage2 |
4.000400E-02 |
| Normal-vs-Stage3 |
3.614200E-01 |
| Normal-vs-Stage4 |
2.648000E-02 |
| Stage1-vs-Stage2 |
1.505540E-02 |
| Stage1-vs-Stage3 |
1.437960E-01 |
| Stage1-vs-Stage4 |
6.418700E-03 |
| Stage2-vs-Stage3 |
1.801310E-03 |
| Stage2-vs-Stage4 |
3.93739999999809E-05 |
| Stage3-vs-Stage4 |
1.393000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.720600E-01 |
| Normal-vs-AfricanAmerican |
9.412200E-01 |
| Normal-vs-Asian |
9.222400E-01 |
| Caucasian-vs-AfricanAmerican |
9.027200E-01 |
| Caucasian-vs-Asian |
6.965600E-01 |
| AfricanAmerican-vs-Asian |
8.754400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.438000E-01 |
| Normal-vs-Female |
7.283600E-01 |
| Male-vs-Female |
3.155600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.411400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.183400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.145400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.182400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.597400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.989400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.761600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.623000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.829600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.386300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.65940000000209E-05 |
| Classical-VS-Follicular |
2.505600E-01 |
| Classical-VS-Other |
7.763200E-01 |
| Classical-VS-Normal |
9.235200E-01 |
| Tall-VS-Follicular |
3.84820000000063E-05 |
| Tall-VS-Other |
2.511400E-01 |
| Tall-VS-Normal |
2.320400E-03 |
| Follicular-VS-Other |
9.529200E-01 |
| Follicular-VS-Normal |
4.063000E-01 |
| Other-VS-Normal |
7.637600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.145600E-01 |
| Normal-vs-N1 |
2.742000E-02 |
| N0-vs-N1 |
1.359560E-03 |
|
|
